Stay updated with breaking news from Daptorum Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 8,800 shares, a drop of 33.8% from the June 30th total of 13,300 shares. Based on an average daily trading volume, of 310,600 […]
/PRNewswire/ -- The "Global Genomics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, announced that the group has submitted t...
Regulatory News: Aptorum Group Limited (the "Company") (NASDAQ:APM, Euronext Paris:APM) announced today that following a comprehensive review of the trading volume, costs and administrative requirements
Regulatory News: Aptorum Group Limited announced today that following a comprehensive review of the trading volume, costs and administrative requirements related to its listing on Euronext Paris,... | June 10, 2023